Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sybil Biermann

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer|February 11, 2004
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139Mark M Zalupski, Cathryn Rankin, James R Ryan, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 23, 2020
Childbearing Decisions in Residency: A Multicenter Survey of Female ResidentsShobha W Stack, Reshma Jagsi, J Sybil Biermann, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 17, 2019
Maternity Leave in Residency: A Multicenter Study of Determinants and Wellness OutcomesShobha W Stack, Reshma Jagsi, J Sybil Biermann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2013
NCCN Task Force Report: Bone Health In Cancer CareJulie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN Task Force Report: Bone Health in Cancer CareJulie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2006
NCCN Task Force Report: Bone Health and Cancer CareRichard L Theriault, J Sybil Biermann, Elizabeth Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaElizabeth J Davis, Rashmi Chugh, Lili Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancerCatherine H Van Poznak, Sarah Temin, Gary C Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma. Clinical practice guidelines in oncologyKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer|February 11, 2004
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139Mark M Zalupski, Cathryn Rankin, James R Ryan, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|June 23, 2020
Childbearing Decisions in Residency: A Multicenter Survey of Female ResidentsShobha W Stack, Reshma Jagsi, J Sybil Biermann, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 17, 2019
Maternity Leave in Residency: A Multicenter Study of Determinants and Wellness OutcomesShobha W Stack, Reshma Jagsi, J Sybil Biermann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2013
NCCN Task Force Report: Bone Health In Cancer CareJulie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN Task Force Report: Bone Health in Cancer CareJulie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2006
NCCN Task Force Report: Bone Health and Cancer CareRichard L Theriault, J Sybil Biermann, Elizabeth Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2015
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaElizabeth J Davis, Rashmi Chugh, Lili Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancerCatherine H Van Poznak, Sarah Temin, Gary C Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline UpdateCatherine Van Poznak, Mark R Somerfield, William E Barlow, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma. Clinical practice guidelines in oncologyKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Pageof 8